1.Guidelines on Implementing Antimicrobial Stewardship Programs in Korea
Young Kyung YOON ; Ki Tae KWON ; Su Jin JEONG ; Chisook MOON ; Bongyoung KIM ; Sungmin KIEM ; Hyung-sook KIM ; Eunjeong HEO ; Shin-Woo KIM ; Korean Society for Antimicrobial Therapy, Korean Society of Infectious Diseases, and Korean Society
Infection and Chemotherapy 2021;53(3):617-659
These guidelines were developed as a part of the 2021 Academic R&D Service Project of the Korea Disease Control and Prevention Agency in response to requests from healthcare professionals in clinical practice for guidance on developing antimicrobial stewardship programs (ASPs). These guidelines were developed by means of a systematic literature review and a summary of recent literature, in which evidence-based intervention methods were used to address key questions about the appropriate use of antimicrobial agents and ASP expansion. These guidelines also provide evidence of the effectiveness of ASPs and describe intervention methods applicable in Korea.
2.Guidelines on Implementing Antimicrobial Stewardship Programs in Korea
Young Kyung YOON ; Ki Tae KWON ; Su Jin JEONG ; Chisook MOON ; Bongyoung KIM ; Sungmin KIEM ; Hyung-sook KIM ; Eunjeong HEO ; Shin-Woo KIM ; Korean Society for Antimicrobial Therapy, Korean Society of Infectious Diseases, and Korean Society
Infection and Chemotherapy 2021;53(3):617-659
These guidelines were developed as a part of the 2021 Academic R&D Service Project of the Korea Disease Control and Prevention Agency in response to requests from healthcare professionals in clinical practice for guidance on developing antimicrobial stewardship programs (ASPs). These guidelines were developed by means of a systematic literature review and a summary of recent literature, in which evidence-based intervention methods were used to address key questions about the appropriate use of antimicrobial agents and ASP expansion. These guidelines also provide evidence of the effectiveness of ASPs and describe intervention methods applicable in Korea.
3.Self-Assessment Questionnaire for Efficient and Safe Evaluation of Patients with Mild COVID-19
Hyeongseok JEONG ; Jooyeon LEE ; Jungok KIM ; Shinhye CHOEN ; Kyung Mok SOHN ; Yeon-Sook KIM ; Sungmin KIEM
Infection and Chemotherapy 2020;52(2):212-215
As the outbreak of coronavirus disease 2019 continues and the number of confirmed cases requiring isolation increases, there is a need for a safe and efficient system to assess patients' condition. We developed and evaluated a self-assessment questionnaire consisting of 23 symptoms with linear-scale scores from 0 to 10. Patients were asked to indicate their worst score for each symptom daily, and medical personnel assessed clinical improvement or deterioration based on the changes in scores. Focused communication on severity of specific symptoms was the primary advantage for the clinicians, and a thorough check for their symptoms was helpful for patients.
4.Development of Antibiotic Classification for Measuring Antibiotic Usage in Korean Hospitals Using a Modified Delphi Method
Bongyoung KIM ; Young Kyung YOON ; Dong-Sook KIM ; Su Jin JEONG ; Song Vogue AHN ; Sun Hee PARK ; Ki Tae KWON ; Hong Bin KIM ; Yoon Soo PARK ; Shin-Woo KIM ; Sungmin KIEM ; Jun Yong CHOI ; ; ;
Journal of Korean Medical Science 2020;35(30):e241-
In 2019, a project designed to develop a system for measuring and comparing antibiotic usage in hospitals was launched in Korea. As part of this project, we developed a means to classify antibiotic usage in Korean hospitals using a modified Delphi method. In results, the following categories of antibiotic classification were accepted for use in Korean hospitals: 1) broad-spectrum antibacterial agents predominantly used for hospital-onset infections in adults, 2) broad-spectrum antibacterial agents predominantly used for community-acquired infections in adults, 3) antibacterial agents predominantly used for resistant gram-positive infections in adults, 4) narrow-spectrum beta-lactam agents in adults, 5) antibacterial agents predominantly used for extensive antibiotic resistant gram-negative bacteria in adults, and 6) total antibacterial agents.
5.Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.
Mi Suk LEE ; Jee Youn OH ; Cheol In KANG ; Eu Suk KIM ; Sunghoon PARK ; Chin Kook RHEE ; Ji Ye JUNG ; Kyung Wook JO ; Eun Young HEO ; Dong Ah PARK ; Gee Young SUH ; Sungmin KIEM
Infection and Chemotherapy 2018;50(2):160-198
Community-acquired pneumonia is common and important infectious disease in adults. This work represents an update to 2009 treatment guideline for community-acquired pneumonia in Korea. The present clinical practice guideline provides revised recommendations on the appropriate diagnosis, treatment, and prevention of community-acquired pneumonia in adults aged 19 years or older, taking into account the current situation regarding community-acquired pneumonia in Korea. This guideline may help reduce the difference in the level of treatment between medical institutions and medical staff, and enable efficient treatment. It may also reduce antibiotic resistance by preventing antibiotic misuse against acute lower respiratory tract infection in Korea.
Adult*
;
Communicable Diseases
;
Community-Acquired Infections
;
Diagnosis
;
Drug Resistance, Microbial
;
Humans
;
Korea
;
Medical Staff
;
Pneumonia*
;
Respiratory Tract Infections
6.Rapidly Fatal Emphysematous Osteomyelitis with Multiple Septic Emboli and Liver Abscess Caused by Klebsiella pneumoniae.
Yong Kyun KIM ; Kyeong Min JO ; Ji Hoon JANG ; Chang Min HEO ; Jae Ha LEE ; Jin Han PARK ; Sunyoung KIM ; Hang Jae JANG ; Hyeon Kuk KIM ; Sungmin KIEM
Infection and Chemotherapy 2018;50(3):268-273
Emphysematous osteomyelitis, characterized by intraosseous gas, is a rare but potentially fatal condition that requires prompt diagnosis and aggressive therapy. Causative organisms are members of the bacterial family Enterobacteriaceae or anaerobes in most cases and significant comorbidities such as diabetes mellitus and malignancy, may predispose an individual to the development of emphysematous osteomyelitis. We report a case of extensive emphysematous osteomyelitis via hematogenous spread from Klebsiella pneumoniae liver abscess, complicated by gas-containing abscesses in adjacent soft tissues and epidural space, and multiple systemic septic emboli in a diabetic patient.
Abscess
;
Comorbidity
;
Diabetes Mellitus
;
Diagnosis
;
Enterobacteriaceae
;
Epidural Space
;
Humans
;
Klebsiella pneumoniae*
;
Klebsiella*
;
Liver Abscess*
;
Liver*
;
Osteomyelitis*
7.Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.
Mi Suk LEE ; Jee Youn OH ; Cheol In KANG ; Eu Suk KIM ; Sunghoon PARK ; Chin Kook RHEE ; Ji Ye JUNG ; Kyung Wook JO ; Eun Young HEO ; Dong Ah PARK ; Gee Young SUH ; Sungmin KIEM
Infection and Chemotherapy 2018;50(2):160-198
Community-acquired pneumonia is common and important infectious disease in adults. This work represents an update to 2009 treatment guideline for community-acquired pneumonia in Korea. The present clinical practice guideline provides revised recommendations on the appropriate diagnosis, treatment, and prevention of community-acquired pneumonia in adults aged 19 years or older, taking into account the current situation regarding community-acquired pneumonia in Korea. This guideline may help reduce the difference in the level of treatment between medical institutions and medical staff, and enable efficient treatment. It may also reduce antibiotic resistance by preventing antibiotic misuse against acute lower respiratory tract infection in Korea.
Adult*
;
Communicable Diseases
;
Community-Acquired Infections
;
Diagnosis
;
Drug Resistance, Microbial
;
Humans
;
Korea
;
Medical Staff
;
Pneumonia*
;
Respiratory Tract Infections
8.Rapidly Fatal Emphysematous Osteomyelitis with Multiple Septic Emboli and Liver Abscess Caused by Klebsiella pneumoniae.
Yong Kyun KIM ; Kyeong Min JO ; Ji Hoon JANG ; Chang Min HEO ; Jae Ha LEE ; Jin Han PARK ; Sunyoung KIM ; Hang Jae JANG ; Hyeon Kuk KIM ; Sungmin KIEM
Infection and Chemotherapy 2018;50(3):268-273
Emphysematous osteomyelitis, characterized by intraosseous gas, is a rare but potentially fatal condition that requires prompt diagnosis and aggressive therapy. Causative organisms are members of the bacterial family Enterobacteriaceae or anaerobes in most cases and significant comorbidities such as diabetes mellitus and malignancy, may predispose an individual to the development of emphysematous osteomyelitis. We report a case of extensive emphysematous osteomyelitis via hematogenous spread from Klebsiella pneumoniae liver abscess, complicated by gas-containing abscesses in adjacent soft tissues and epidural space, and multiple systemic septic emboli in a diabetic patient.
Abscess
;
Comorbidity
;
Diabetes Mellitus
;
Diagnosis
;
Enterobacteriaceae
;
Epidural Space
;
Humans
;
Klebsiella pneumoniae*
;
Klebsiella*
;
Liver Abscess*
;
Liver*
;
Osteomyelitis*
9.Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute Infections.
Yong Kyun KIM ; Jin Ah JUNG ; Hyang Ki CHOI ; In Gyu BAE ; Won Suk CHOI ; Jian HUR ; Sung Joon JIN ; Shin Woo KIM ; Ki Tae KWON ; Sang Rok LEE ; Jae Gook SHIN ; Sungmin KIEM
Infection and Chemotherapy 2016;48(3):209-215
BACKGROUND: For more effective and safer usage of antibiotics, the dosing strategy should be individualized based on the patients’ characteristics, including race. The aim of this study was to investigate the population pharmacokinetic (PK) profiles of piperacillin and tazobactam in Korean patients with acute infections. MATERIALS AND METHODS: At least four consecutive 2/0.25 g or 4/0.5 g doses of piperacillin/tazobactam (TZP) were intravenously infused over 1 h every 8 h for patients with creatinine clearance (CL(cr)) ≤50 ml/min or CL(cr) >50 mL/min, respectively. Blood samples from 33 patients at a steady-state were taken pre-dose and at 0 min, 30 min, and 4-6 h after the fourth infusion. The population PK analysis was conducted using a non-linear mixed-effects method. A likelihood ratio test was used to select significant covariates, with significance levels of P <0.05 for selection and P <0.01 for elimination. RESULTS: Both piperacillin PK and tazobactam PK were well described by a two-compartment model with first-order elimination. Creatinine clearance and body weight, as covariates on clearance (CL) and volume of central compartment (V1), were selected among the covariates possibly affecting PK parameters of both drugs. CL was defined as CL = 2.9 + 4.03 × CL(cr)/47 for piperacillin and CL = 1.76 + 4.81 × CL(cr)/47 for tazobactam. V1 was defined as V1 = 19.5 × weight/60 for piperacillin and V1 = 22.6 × weight/60 for tazobactam. CONCLUSION: The PK profiles of TZP at a steady-state in Korean patients with acute infections were well described by a two-compartment model with first-order elimination. Both piperacillin and tazobactam clearances were significantly influenced by creatinine clearance.
Anti-Bacterial Agents
;
Body Weight
;
Continental Population Groups
;
Creatinine
;
Humans
;
Methods
;
Piperacillin
10.Interpretation of Epithelial Lining Fluid Concentrations of Antibiotics against Methicillin Resistant Staphylococcus aureus.
Sungmin KIEM ; Jerome J SCHENTAG
Infection and Chemotherapy 2014;46(4):219-225
Although antibiotics whose epithelial lining fluid (ELF) concentrations are reported high tend to be preferred in treatment of pneumonia, measurement of ELF concentrations of antibiotics could be misled by contamination from lysis of ELF cells and technical errors of bronchoalveolar lavage (BAL). In this review, ELF concentrations of anti-methicillin resistant Staphylococcus aureus (MRSA) antibiotics were interpreted considering above confounding factors. An equation used to explain antibiotic diffusion into CSF (cerebrospinal fluid) was adopted: ELF/free serum concentration ratio = 0.96 + 0.091 x ln (partition coefficient / molecular weight1/2). Seven anti-MRSA antibiotics with reported ELF concentrations were fitted to this equation to see if their ELF concentrations were explainable by the penetration capacity only. Then, outliers were modeled under the assumption of varying contamination from lysed ELF cells (test range 0-10% of ELF volume). ELF concentrations of oritavancin, telavancin, tigecycline, and vancomycin were well described by the diffusion equation, with or without additional impact from cell lysis. For modestly high ELF/free serum concentration ratio of linezolid, technical errors of BAL should be excluded. Although teicoplanin and iclaprim showed high ELF/free serum ratios also, their protein binding levels need to be cleared for proper interpretation. At the moment, it appears very premature to use ELF concentrations of anti-MRSA antibiotics as a relevant guide for treatment of lung infections by MRSA.
Anti-Bacterial Agents*
;
Bronchoalveolar Lavage
;
Diffusion
;
Linezolid
;
Lung
;
Methicillin Resistance*
;
Methicillin-Resistant Staphylococcus aureus
;
Pneumonia
;
Protein Binding
;
Staphylococcus aureus*
;
Teicoplanin
;
Vancomycin

Result Analysis
Print
Save
E-mail